The company has 6 months to get the shares up above $1.00 or it goes to the junk category and off the big board. Drug stores are feeling the pinch of the economic slow down, depending on where the stood financially before hand, has an effect on where they are today. Granted Rite Aid had some...
Posted to
The Medical Quack .... by Barbara Duck
on 10-17-2008
Filed under: Medically Related, Insurance, Pharma/FDA News, drugs, healthcare, Prescriptions, Pharmaceuticals, Stocks, Rite Aid
This article states part of the reporting system will include information on the willingness of a doctor to use genetic testing, well first of all we need to help the doctors to bring this full circle with the integration into the clinical side of this, as I have spoken to many MDs and they are aware...
Posted to
The Medical Quack .... by Barbara Duck
on 10-06-2008
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Education, FDA, Pharmaceuticals, Pharmacogenomics, DNA Testing
This article brings up a good point, when a patient has no other choices and the potential of a new drug could offer some relief, what is the verdict at this point? The FDA has turned it's way of thinking around now to being much more conservative on the drugs that are approved. Do the drug companies...
One more way for the information to run queries to cherry pick applicants is accomplished. When you apply for insurance, the fine writing will usually state that you are giving permission to check any medical information and records and, yes, this includes prescriptions. Even the $4.00 generic...
Thomas Pogge, Professor of Philosophy and International Affairs at Yale University in the United States to speak out on reform with the pharmaceutical industry on July 17th in the UK with a new proposal and business model proposition called the Health Impact Fund in the interest of protecting human rights...
With all the heat of late on financial contributions for CME credit, Pfizer is the first one out of the barrel to restructure where and where they will not offer funding. In other words it appears to be an evaluation process to make sure that the CME funds go where they should, towards education...
Probably not a bad idea to look in to who and where some of the outsource companies would be. In other words would the FDA be outsourcing to US companies or would these too be companies located in other countries? Would there be an exclusion for the same country to manufacture and also inspect...